Literature DB >> 32013379

Poly(lactic-co-glycolic) Acid-Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin.

Sajedeh Maghrebi1,2, Paul Joyce1,2, Manasi Jambhrunkar1,2, Nicky Thomas1,2, Clive A Prestidge1,2.   

Abstract

An urgent demand exists for the development of effective carrier systems that systematically enhance the cellular uptake and localization of antibiotic drugs for the treatment of intracellular pathogens. Commercially available antibiotics suffer from poor cellular penetration, restricting their efficacy against pathogens hosted and protected within phagocytic cells. In this study, the potency of the antibiotic rifampicin against intracellular small colony variants of Staphylococcus aureus was improved through encapsulation within a strategically engineered cell-penetrant delivery system, composed of lipid nanoparticles encapsulated within a poly(lactic-co-glycolic) acid (PLGA) nanoparticle matrix. PLGA-lipid hybrid (PLH) microparticles were synthesized through the process of spray drying, whereby rifampicin was loaded within both the polymer and lipid phases, to create a nanoparticle-in-microparticle system capable of efficient redispersion in aqueous biorelevant media and with programmable release kinetics. The ability of PLH particles to disintegrate into nanoscale agglomerates of the precursor nanoparticles was shown to be instrumental in optimizing rifampicin uptake in RAW264.7 macrophages, with a 7.2- and 1.6-fold increase in cellular uptake, when compared to the pure drug and PLGA microparticles (of an equivalent initial particle size), respectively. The enhanced phagocytosis and extended drug release mechanism (under the acidic macrophage environment) associated with PLH particles induced a 2.5-log reduction in colony forming units compared to initial colonies at 2.50 μg/mL rifampicin dose. Thus, the ability of PLH particles to reduce the intracellular viability of S. aureus, without demonstrating significant cellular toxicity, satisfies the requirements necessary for the safe and efficacious delivery of antibiotics to macrophages for the treatment of intracellular infections.

Entities:  

Keywords:  Staphylococcus aureus; cellular uptake; intracellular bacteria; intracellular infection; macrophage; polymer−lipid hybrid; rifampicin

Year:  2020        PMID: 32013379     DOI: 10.1021/acsami.9b22991

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  4 in total

1.  Enhancing the Cellular Uptake and Antibacterial Activity of Rifampicin through Encapsulation in Mesoporous Silica Nanoparticles.

Authors:  Paul Joyce; Hanna Ulmefors; Sajedeh Maghrebi; Santhni Subramaniam; Anthony Wignall; Silver Jõemetsa; Fredrik Höök; Clive A Prestidge
Journal:  Nanomaterials (Basel)       Date:  2020-04-24       Impact factor: 5.076

2.  Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.

Authors:  Md Khalid Anwer; Essam A Ali; Muzaffar Iqbal; Mohammed Muqtader Ahmed; Mohammed F Aldawsari; Ahmed Al Saqr; Mohd Nazam Ansari; M Ali Aboudzadeh
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

Review 3.  Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances.

Authors:  Antonios Vlachopoulos; Georgia Karlioti; Evangelia Balla; Vasileios Daniilidis; Theocharis Kalamas; Myrika Stefanidou; Nikolaos D Bikiaris; Evi Christodoulou; Ioanna Koumentakou; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Pharmaceutics       Date:  2022-02-04       Impact factor: 6.321

4.  Solvent-Free Fabrication of Biphasic Lipid-Based Microparticles with Tunable Structure.

Authors:  Serena Bertoni; Beatrice Albertini; Joanna Ronowicz-Pilarczyk; Natalia Calonghi; Nadia Passerini
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.